FI954050L - Lääkekoostumuksia - Google Patents

Lääkekoostumuksia Download PDF

Info

Publication number
FI954050L
FI954050L FI954050A FI954050A FI954050L FI 954050 L FI954050 L FI 954050L FI 954050 A FI954050 A FI 954050A FI 954050 A FI954050 A FI 954050A FI 954050 L FI954050 L FI 954050L
Authority
FI
Finland
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
FI954050A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI954050A0 (fi
FI954050A7 (fi
Inventor
Mary Kay Mccauley
Kenneth Philip Moder
Jeffrey Lynn Speakman
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI954050A0 publication Critical patent/FI954050A0/fi
Publication of FI954050A7 publication Critical patent/FI954050A7/fi
Publication of FI954050L publication Critical patent/FI954050L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26—Radicals substituted by sulfur atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicinal Preparation (AREA)
FI954050A 1994-08-30 1995-08-29 Lääkekoostumuksia FI954050L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/298,486 US5470865A (en) 1994-08-30 1994-08-30 Pharmaceutical composition

Publications (3)

Publication Number Publication Date
FI954050A0 FI954050A0 (fi) 1995-08-29
FI954050A7 FI954050A7 (fi) 1996-03-02
FI954050L true FI954050L (fi) 1996-03-02

Family

ID=23150736

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954050A FI954050L (fi) 1994-08-30 1995-08-29 Lääkekoostumuksia

Country Status (24)

Country Link
US (1) US5470865A (de)
EP (1) EP0704214B1 (de)
JP (1) JPH0892087A (de)
KR (1) KR960006921A (de)
CN (1) CN1127635A (de)
AT (1) ATE192039T1 (de)
AU (1) AU700488B2 (de)
BR (1) BR9503832A (de)
CA (1) CA2157240A1 (de)
CO (1) CO4410183A1 (de)
CZ (1) CZ189395A3 (de)
DE (1) DE69516475T2 (de)
ES (1) ES2145221T3 (de)
FI (1) FI954050L (de)
HU (1) HUT72672A (de)
IL (1) IL115012A0 (de)
NO (1) NO952825L (de)
NZ (1) NZ272833A (de)
PE (1) PE33696A1 (de)
PH (1) PH31452A (de)
PL (1) PL310207A1 (de)
TR (1) TR199500885A2 (de)
YU (1) YU57495A (de)
ZA (1) ZA957281B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4828678B2 (ja) * 1998-11-18 2011-11-30 武田薬品工業株式会社 圧縮成形物
KR20010068707A (ko) * 2000-01-07 2001-07-23 최용준 시계줄
JP2001240534A (ja) * 2000-02-29 2001-09-04 Bio Kagaku Kk 液状組成物
KR102178793B1 (ko) * 2019-04-17 2020-11-13 황용석 순금 장식연결구

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904792A (en) * 1980-10-02 1990-02-27 Eli Lilly And Company N-thiazolymethylthioalkyl-N'-alkylamidines and related compounds
US4760075A (en) * 1980-10-02 1988-07-26 Eli Lilly And Company N-thiazolylmethylthioalkyl-N-alkyl-amidines and related compounds
US4375547A (en) * 1980-10-02 1983-03-01 Eli Lilly And Company N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine
US4382090A (en) * 1980-10-02 1983-05-03 Eli Lilly And Company N-Thiazolylmethylthioalkyl-N'alkylamidines and related compounds
US4587344A (en) * 1983-02-07 1986-05-06 Eli Lilly And Company Isothiourea synthesis process
AU559639B2 (en) * 1983-02-07 1987-03-19 Eli Lilly And Company Synthesis of nizatidine
EP0230127A1 (de) * 1985-12-18 1987-07-29 Eli Lilly And Company Verfahren zur Herstellung von Nizatidin
US4777260A (en) * 1985-12-18 1988-10-11 Eli Lilly And Company Synthesis of nizatidine intermediate
US4857344A (en) 1986-12-31 1989-08-15 Del Monte Corporation Method for treating pineapple to inhibit browning
DE3784698D1 (de) * 1987-04-06 1993-04-15 Heumann Pharma Gmbh & Co Verfahren zur herstellung von nitroethenderivaten.
DE68910308D1 (de) * 1989-05-10 1993-12-02 Council Scient Ind Res Verfahren zur Herstellung von 1-amino-substituierten 1-thio-substituierten 2-Nitro Alkenen.
US5075114A (en) * 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
CA2055661A1 (en) * 1990-12-21 1992-06-22 Manley A. Paulos Treatment of upset stomach associated with heartburn, sour stomach or acid indigestion with an effervescent h2 blocker formulation
US5334725A (en) * 1991-05-21 1994-08-02 Eli Lilly And Company 2-aminomethyl-4-exomethylenethiazoline epoxides
US5503846A (en) * 1993-03-17 1996-04-02 Cima Labs, Inc. Base coated acid particles and effervescent formulation incorporating same

Also Published As

Publication number Publication date
CO4410183A1 (es) 1997-01-09
KR960006921A (ko) 1996-03-22
NO952825D0 (no) 1995-07-17
NO952825L (no) 1996-03-01
AU700488B2 (en) 1999-01-07
CZ189395A3 (en) 1996-03-13
FI954050A0 (fi) 1995-08-29
EP0704214A1 (de) 1996-04-03
HU9502542D0 (en) 1995-10-30
US5470865A (en) 1995-11-28
ATE192039T1 (de) 2000-05-15
TR199500885A2 (tr) 1996-06-21
CN1127635A (zh) 1996-07-31
FI954050A7 (fi) 1996-03-02
CA2157240A1 (en) 1996-03-01
BR9503832A (pt) 1996-09-10
JPH0892087A (ja) 1996-04-09
PE33696A1 (es) 1996-08-29
ZA957281B (en) 1997-02-28
HUT72672A (en) 1996-05-28
PL310207A1 (en) 1996-03-04
IL115012A0 (en) 1996-01-31
EP0704214B1 (de) 2000-04-26
YU57495A (sh) 1999-07-28
PH31452A (en) 1998-11-03
NZ272833A (en) 1997-04-24
ES2145221T3 (es) 2000-07-01
DE69516475D1 (de) 2000-05-31
DE69516475T2 (de) 2000-09-28
AU3033495A (en) 1996-03-14

Similar Documents

Publication Publication Date Title
FI20071025L (fi) Farmaseuttisia koostumuksia
IS4706A (is) Lyfjasamsetningar
ID18352A (id) Komposisi-komposisi farmasi
NO962606L (no) Farmasöytisk sammensetning
FI965202L (fi) Farmaseuttiset takriinikoostumukset
FI991302L (fi) Parannetut farmaseuttiset koostumukset
BR9507768A (pt) Composição farmacêutica
FI943705L (fi) Farmaseuttiset koostumukset
IS2515B (is) Lyfjasamsetningar
LV11727A (lv) Farmaceitiska kompozicija
PT941100E (pt) Composicoes farmaceuticas
ITMI941169A0 (it) Formulazioni farmaceutiche
EE200000330A (et) Farmatseutilised kompositsioonid
ITMI942166A0 (it) Composizioni farmaceutiche miorilassanti
FI973280A7 (fi) Farmaseuttinen koostumus
FI940726L (fi) Farmaseuttiset koostumukset
FI962738A7 (fi) Farmaseuttiset koostumukset
FI954050A7 (fi) Lääkekoostumuksia
ITMI962628A0 (it) Composizione farmaceutica
BR9605777A (pt) Composição farmacêutica
NO994436D0 (no) Farmasöytiske sammensetninger
NO964309D0 (no) Farmasöytisk sammensetning
IT1272935B (it) Composizione farmaceutica contenente n-acetil-cisteina
SE9402924D0 (sv) Novel pharmaceutical composition
KR960016881A (ko) 제약 조성물